Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia
Adriana Seber; Claudio Galvão de CastroJunior; Lucila N. Kerbauy; Alexandre V. Hirayama; Carmem Bonfim; Juliana Folloni Fernandes; Mair Souza; Rony Schafell; Samir Nabhan; Sandra Regina Loggetto; Belinda Pinto Simões; Vanderson Rocha; Marcos de Lima; Renato L. Guerino-Cunha; Henrique Bittencourt;
Hematol Transfus Cell Ther. 2021;43 Supl 2:S13-21
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
Alvaro J. Alencar; Alexandre V. Hirayama; Diego V. Clé; Marco Aurélio Salvino; Guilherme Perini; Celso Arrais; Otávio Baiocchi; Leonardo Carvalho Palma; Iago Colturato; Jorge Vaz; Ricardo Chiattone; Marcos de Lima; Jayr Schmidt Filho; Samir Nabhan; Vanderson Rocha; Renato L. Guerino-Cunha; Carlos S. Chiattone;
Hematol Transfus Cell Ther. 2021;43 Supl 2:S22-9
CAR T-cell therapy-related lumbosacral polyradiculopathy with myelitis and stiff person syndrome with response to intravenous immunoglobulin and corticosteroids in a patient with acute lymphoblastic leukemia
Hannah Goulart; Kevin Elmore; Stephen Scelsa; Daniel Park; Alla Keyzner; Uroosa Ibrahim;
10.1016/j.htct.2025.103932